Chuanlei Liu

Title: Chuanlei Liu: Innovator in Pharmaceutical Composition

Introduction

Chuanlei Liu is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance therapeutic efficacy.

Latest Patents

Chuanlei Liu holds a patent for a composition comprising aflibercept and a variant thereof. This patent describes a composition where the variant is a truncation variant with a truncated VEGF binding portion of aflibercept. The content of the truncation variant is specified to be less than or equal to about 20% by mass percentage. Additionally, the patent includes a pharmaceutical formulation comprising this composition, along with methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products.

Career Highlights

Chuanlei Liu is associated with Qilu Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating effective therapeutic solutions that address various medical needs.

Collaborations

Chuanlei Liu collaborates with esteemed colleagues such as Yue Yu and Guijiang Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chuanlei Liu's contributions to pharmaceutical compositions exemplify the importance of innovation in healthcare. His work not only advances scientific knowledge but also has the potential to improve patient outcomes through enhanced therapeutic formulations.